BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,302,000 | -13.2% | 10,985 | +0.9% | 0.04% | -22.2% |
| Q4 2021 | $1,500,000 | -76.7% | 10,885 | -85.5% | 0.05% | -76.9% |
| Q4 2020 | $6,428,000 | -63.9% | 75,000 | -77.1% | 0.23% | -85.1% |
| Q4 2019 | $17,802,000 | +25.5% | 327,000 | -3.8% | 1.57% | -35.4% |
| Q3 2019 | $14,185,000 | +8.0% | 340,000 | +13.3% | 2.42% | +21.5% |
| Q2 2019 | $13,137,000 | +750.8% | 300,000 | +900.0% | 2.00% | +806.8% |
| Q1 2019 | $1,544,000 | +14.9% | 30,000 | -42.5% | 0.22% | -72.3% |
| Q1 2018 | $1,344,000 | +18.1% | 52,186 | +23.7% | 0.79% | +66.8% |
| Q4 2017 | $1,138,000 | – | 42,186 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |